Cairo-Mubasher: Minapharm Pharmaceuticals posted a 39% decline in consolidated net profits for the fiscal year 2014, down to EGP 49.3 million compared with EGP 81.2 million in net profits a year earlier.
Meanwhile, standalone net profits for the same year amounted to EGP 44.5 million, compared with EGP 53.6 million in FY13.
Consolidated financial results for the first nine months of FY14 showed an 11.4% fall in net profits to EGP 49.6 million, from EGP 56 million.
